Emergent BioSolutions Inc. (EBS) KPIs and segments
Close on Nov 16, 2026Market cap $297.90MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Emergent BioSolutions's business
Emergent BioSolutions's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCM Products($M) | 168 | 102 | 99.2 | 143 | 58.4 | 157 | 117 | 174 | 63.4 | 155 | 138 | 108 | |
Commercial Products($M) | 52.4 | 42.9 | 38.4 | 74.9 | 67.5 | 45.3 | 65.1 | 95.3 | 120 | 119 | 111 | 142 | |
Earlier reporting (last reported 2023)1 | |||||||||||||
Product and services sales, net($M) | 227 | 150 | 144 | 222 | 130 | 209 | 189 | 284 | 248 | 292 | |||
MCM Product sales($M) | 168 | 102 | 99.2 | 143 | 58.4 | 157 | 117 | 174 | 63.4 | 155 | 138 | 108 | |
Commercial Product sales($M) | 52.4 | 42.9 | 38.4 | 74.9 | 67.5 | 45.3 | 65.1 | 95.3 | 120 | 119 | 111 | 142 | |
All other revenue($M) | 13.9 | 11.4 | 11.1 | 13.7 | 15 | 20.3 | 12.8 | 24.3 | 71.3 | 26.5 | |||
Contracts and grants($M) | 7.50 | 6.40 | 4.90 | 9.10 | 10.6 | 13.1 | 5.40 | 10 | 6.60 | 8 | 6.70 | 6.50 | |
Earlier reporting (last reported 2024)2 | |||||||||||||
MCM Products($M) | 116 | 65.6 | 53.8 | 105 | 32.5 | 108 | 49.4 | 126 | 35.1 | 93.6 | 42 | 39.1 | |
Commercial Products($M) | 16.2 | 16.1 | 11.8 | 32.3 | 31.3 | 20.8 | 31.9 | 48.1 | 66.6 | 66.4 | 61 | 82.1 | |
Earlier reporting (last reported 2024)2 | |||||||||||||
MCM Products($M) | 116 | 65.6 | 53.8 | 105 | 32.5 | 108 | 49.4 | 120 | 32.3 | 93.2 | 40.8 | 35.2 | |
Commercial Products($M) | 16.2 | 16.1 | 11.8 | 32.3 | 31.3 | 20.8 | 31.9 | 48.1 | 66.6 | 66.4 | 61 | 82.1 | |
Earlier reporting (last reported 2024)2 | |||||||||||||
Earlier reporting (last reported 2024)3 | |||||||||||||
Remaining performance obligations (RPO)($M) | 269 | 248 | 323 | 297 | 270 | 322 | 384 | 279 | 409 | ||||
27 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?